XML 51 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information (Tables)
6 Months Ended
Jun. 30, 2018
Segment Information [Abstract]  
Special item charges
Three Months Ended
June 30, 2018June 30, 2017
(In millions)Before-taxAfter-taxBefore-taxAfter-tax
Transaction-related costs - see Note 3$130$109$16$(47)
Total impact from special items$130$109$16$(47)
Six Months Ended
June 30, 2018June 30, 2017
Before-taxAfter-taxBefore-taxAfter-tax
Transaction-related costs - see Note 3$190$159$79$2
Long-term care guaranty fund assessment - see Note 16(D)--12983
Total impact from special items$190$159$208$85
Summarized segment financial information
(In millions)Global Health CareGlobal Supplemental BenefitsGroup Disability and LifeOther OperationsCorporateTotal
Three Months Ended June 30, 2018
Premiums, fees and other revenues and mail order pharmacy revenues (1)$9,025$1,050$1,031$33$(11)$11,128
Net investment income1253696887352
Less net realized investment (losses) from equity method subsidiaries (2)-(20)---(20)
Operating revenues$9,150$1,106$1,127$121$(4)$11,500
Total revenues$9,155$1,075$1,132$119$(4)$11,477
Shareholders' net income (loss)$780$86$107$19$(186)$806
After-tax adjustments to reconcile to adjusted income from operations
Net realized investment (gains) losses (2)(4)27(4)2122
Amortization of other acquired intangible assets, net135---18
Special item
Transaction-related costs----109109
Adjusted income (loss) from operations$789$118$103$21$(76)$955
Three Months Ended June 30, 2017
Premiums, fees and other revenues and mail order pharmacy revenues (1)$8,100$924$1,023$30$(11)$10,066
Net investment income923189888308
Operating revenues$8,192$955$1,112$118$(3)$10,374
Total revenues$8,224$954$1,134$116$(3)$10,425
Shareholders' net income (loss)$599$101$97$17$(1)$813
After-tax adjustments to reconcile to adjusted income from operations
Net realized investment (gains) losses(22)-(14)2-(34)
Amortization of other acquired intangible assets, net144---18
Special items
Transaction-related costs----(47)(47)
Adjusted income (loss) from operations$591$105$83$19$(48)$750
(1) Includes the Company's share of the earnings of its joint ventures in China and India in the Global Supplemental Benefits segment.
(2) Beginning in 2018, the Company's share of the realized investment results of equity method joint ventures in the Global Supplemental Benefits segment (reported in other revenues) is excluded from operating revenues and adjusted income from operations.

(In millions)Global Health CareGlobal Supplemental BenefitsGroup Disability and LifeOther OperationsCorporateTotal
Six Months Ended June 30, 2018
Premiums, fees and other revenues and mail order pharmacy revenues (1)$17,999$2,116$2,057$64$(24)$22,212
Net investment income2407018617312681
Less net realized investment (losses) on equity method subsidiaries (2)-(22)---(22)
Operating revenues$18,239$2,208$2,243$237$(12)$22,915
Total revenues$18,224$2,175$2,232$239$(13)$22,857
Shareholders' net income (loss)$1,622$191$161$48$(301)$1,721
After-tax adjustments to reconcile to adjusted income from operations
Net realized investment losses (gains) (2)11289(3)247
Amortization of other acquired intangible assets2711---38
Special item
Transaction-related costs----159159
Adjusted income (loss) from operations$1,660$230$170$45$(140)$1,965
Six Months Ended June 30, 2017
Premiums, fees and other revenues and mail order pharmacy revenues (1)$16,295$1,805$2,055$60$(24)$20,191
Net investment income1845917817416611
Operating revenues$16,479$1,864$2,233$234$(8)$20,802
Total revenues$16,537$1,876$2,263$231$(8)$20,899
Shareholders' net income (loss)$1,143$178$156$37$(103)$1,411
After-tax adjustments to reconcile to adjusted income from operations
Net realized investment (gains) losses(38)(9)(20)2-(65)
Amortization of other acquired intangible assets2810---38
Special items
Transaction-related costs----22
Long-term care guaranty fund assessment68-15--83
Total special items68-15-285
Adjusted income (loss) from operations$1,201$179$151$39$(101)$1,469
(1) Includes the Company's share of the earnings of its joint ventures in China and India in the Global Supplemental Benefits segment.
(2) Beginning in 2018, the Company's share of the realized investment results of equity method joint ventures in the Global Supplemental Benefits segment (reported in other revenues) is excluded from operating revenues and adjusted income from operations.
Revenue from external customers
(In millions)Three Months EndedSix Months Ended
June 30,June 30,
2018201720182017
Premiums by product (ASC 944 - insurance activities)
Global Health Care
Commercial
Guaranteed cost$2,046$1,522$4,045$3,065
Experience-rated7367271,4751,454
Stop loss9938561,9731,708
International health care5154791,028954
Dental482441961882
Other259243517489
Government
Medicare1,4611,3892,9592,850
Medicaid243273478553
Medicare Part D189198417432
Total Global Health Care6,9246,12813,85312,387
Disability5104911,015992
Life, Accident and Supplemental Health1,5511,4133,0902,780
Total premiums from ongoing operations8,9858,03217,95816,159
Fees (ASC 606 - service activities)
Global Health Care1,3331,2132,6592,433
Global Supplemental Benefits 871512
Group Disability and Life25255052
Total fees from ongoing operations1,3661,2452,7242,497
Mail order pharmacy (ASC 606 - service activities)7587571,4751,467
Other 19325568
Total revenues from external customers$11,128$10,066$22,212$20,191